Cost-effectiveness of dopamine agonists and monoamine oxidase B inhibitors in Parkinson’s
Background The PD MED study reported small but persistent benefits in patient-rated mobility scores and quality of life from initiating therapy with levodopa compared with levodopa-sparing therapies in early Parkinson's disease (PD). Objectives The objective was to estimate the cost-effectiven...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Wiley
2021
|